Neuro-Developmental Treatment Association Neuro-Developmental
Treatment Association
Connect with us on LinkedIn Become a fan on Facebook Follow NDTA on Twitter


Early Bird Registration Ends April 18th!

Salt Lake City, Utah
May 18-20, 2018
Pre-Conference: May 17
Registration Now Open!

Register Today!



2018 Award of Excellence Recipient

NDTA is proud and honored to announce Lezlie Adler, MA, OTR/L, C/NDT as NDTA’s 2018 Award of Excellence recipient. Contact the National Office today for tickets to Award of Excellence Luncheon.

Read More!



Assistants Training Course

Calling Assistants! Train and credential in NDT! Register today!

Registration Now Open!



STAY INFORMED

March-April 2018

Aging with a Chronic Neurodisability

Volume 25, Issue 2

VIEW THE LATEST EDITION!



2018 Seminar Catalog NOW Available!

Interested in hosting a seminar?

Choose a seminar from the catalog OR create a custom course!

VIEW CATALOG!



NDTA MEMBER EXCLUSIVE DISCOUNT!

Members save 25% on Neuro-Developmental Treatment: A Guide to Clinical Practice

Click Here to find out how to save! Visit www.thieme.com to purchase today!

Purchase Book Here!



NDT CERTIFICATION

Click below for the latest NDT Certification info!

CLICK HERE FOR MORE!



Discussion Board

Join the Discussion!

Click here to visit the Discussion Board!!



Journal Subscription

New Member Benefit - Online Journal Access to Developmental Medicine & Child Neurology! Visit Member News for complete directions!

Member News!


Advertise Here
Search the Network Archives for:
September - October 2013 • From Research to Clinical Practice
Volume 20, Issue 5
A Case Presentation describing the Effects of NDT: Treatment with a Multidisciplinary Approach
Opsoclonus Myoclonus Ataxia Syndrome
By Snehal Deshpande (Physiotherapist, C/NDT,SI Trained, PGDHHM); Nargis Khan (Physiotherapist, C/NDT); Anup Pednekar (Physiotherapist); Anaita Hegde (MD, MRCPCH, Consulting Neurophysician); Milka Gain
Opsoclonus Myoclonus Syndrome (OMS) also known as Opsoclonus Myoclonus Ataxia (OMA) is an extremely rare neurological disease which appears to be due to the breakdown of an autoimmune process involving the nervous system. It is a paraneoplastic neurological syndrome of children and adults, meaning that the neurological impairments seen in OMS are the systemic consequences of the disease process as opposed to lesions of local causation. Click for more



2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | More

® 2018 NDTA™ Neuro-Developmental Treatment Association. All rights reserved.
1540 S. Coast Highway, Ste 204, Laguna Beach, CA 92651
Phone: 800-869-9295 Fax: 949-376-3456
Accessibility  |  Disclaimer  |  Linking Policy